Bioxodes is a clinical stage biotech company specialized in the development of novel therapeutics using molecules derived from nature to prevent thrombosis and inflammatory processes.
Bioxodes recently published a review article highlighting the interest of
dual inhibition of factor XIIa and XIa as a therapeutic approach for safe thromboprotection
Bioxodes has a new job opportunity for a
Chief Medical Officer
Mission & Vision
Potential therapeutic applications
Copyright Bioxodes |